Brussels, Belgium

Sandra Morel

This inventor holds 3 USPTO granted patents and 2 published patent applications, plus 1 CIPO patent and 1 EPO patent. Top assignees: National Institute of Health and Medical Research, Centre National De La Recherche Scientifique, Glaxosmithkline Biologicals Sa. Active years: 2003-2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Sandra Morel. Retrieved from https://idiyas.com/inventor/sandra-morel

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 3 

% Patents Active = 66.7

 

 

Average Co-Inventor Count = 4.9

ph-index = 1

Forward Citations = 3(Granted Patents)


Location History:

  • Brussels, BE (2003 - 2016)
  • Rixensart, BE (2022)

Company Filing History:


Years Active: 2003-2022

Loading Chart...
Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Innovations and Contributions of Inventor Sandra Morel

Introduction

Sandra Morel is a prominent inventor based in Brussels, Belgium. She has made significant contributions to the field of immunology, particularly in the prevention and treatment of autoimmune diseases and cancer. With a total of 3 patents, her work has the potential to impact many lives.

Latest Patents

One of her latest patents focuses on the use of adjuvants for the prevention and/or treatment of autoimmune diseases. This invention provides an adjuvant that can be utilized in combating autoimmune conditions. Another notable patent involves an immunogenic composition that comprises a recombinant protein and a peptide corresponding to a tumor antigen, aimed at cancer treatment. This therapeutic composition is particularly relevant for melanoma, incorporating specific epitopes from the HLA*0201 epitope, including Tyr or GnT-V.

Career Highlights

Sandra Morel has worked with esteemed institutions such as the National Institute of Health and Medical Research (Institut National De La Santé Et De La Recherche Médicale) and the Pasteur Institute (Institut Pasteur). Her research and innovations have garnered attention in the scientific community.

Collaborations

Throughout her career, Sandra has collaborated with notable colleagues, including Gilles Dadaglio and Claude Leclerc. These partnerships have further enriched her research endeavors and contributions to the field.

Conclusion

Sandra Morel's innovative work in immunology showcases her dedication to advancing medical science. Her patents and collaborations reflect her commitment to improving health outcomes for individuals affected by autoimmune diseases and cancer.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…